This is a concern, because they excluded studies of prophylaxis (prevention of infection), which is reportedly the strong point of IM.
Prophylaxis is a strong point given it’s potential effect but given that other studies found that currently the evidence for treatment effects is higher then the evidence for prophylaxis, focusing on the issue that’s more studied seems reasonable to me I consider the other points more concerning.
I too would probably take IM if I had CV (or even was exposed) and could get access. ATM it seems likely it would be helpful and the downside seems low.
At the moment that raises the question to me whether it makes sense to order Ivermectin from India (likely takes a month to arrive).
Given that Delta is enough to produce r>1 in the UK in summer while people are more outside and the UK has still a lot of restrictions while having 85% with one vaccination dose and 50% fully vaccinated, Delta Plus already having a mutation that makes it likely better at evade vaccines, a new wave in autumn seems very likely to me.
Prophylaxis is a strong point given it’s potential effect but given that other studies found that currently the evidence for treatment effects is higher then the evidence for prophylaxis, focusing on the issue that’s more studied seems reasonable to me I consider the other points more concerning.
At the moment that raises the question to me whether it makes sense to order Ivermectin from India (likely takes a month to arrive).
Given that Delta is enough to produce r>1 in the UK in summer while people are more outside and the UK has still a lot of restrictions while having 85% with one vaccination dose and 50% fully vaccinated, Delta Plus already having a mutation that makes it likely better at evade vaccines, a new wave in autumn seems very likely to me.